0.4527

6.43% -0.0311

After Hours: .45 -0.0027 -0.60%

Salarius Pharmaceuticals Inc (SLRX)

Overview News Price History Financials Discussions Forecast Stock Split

Salarius Pharmaceuticals Inc stock is traded at $0.4527, with a volume of 573.92K. It is down -6.43% in the last 24 hours and down -33.23% over the past month. Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.

Previous Close:

$0.4838

Open:

$0.47

24h Volume:

573.92K

Relative Volume:

0.21

Market Cap:

$963.02K

Revenue:

$4.70M

Net Income/Loss:

$-4.99M

P/E Ratio:

-0.0705

EPS:

-6.42

Net Cash Flow:

$-5.29M

1W Performance:

-18.58%

1M Performance:

-33.23%

6M Performance:

-72.06%

1Y Performance:

-76.90%

1-Day Range:

$0.4501

$0.48

1-Week Range:

$0.4501

$0.59

52-Week Range:

$0.4501

$7.20

Salarius Pharmaceuticals Inc Stock (SLRX) Company Profile

Name

Salarius Pharmaceuticals Inc

Sector

Healthcare (1156)

Industry

Biotechnology (642)

Phone

346-772-0346

Address

2450 HOLCOMBE BLVD, HOUSTON

Employee

Twitter

@SalariusPharma

Next Earnings Date

2024-11-07

Latest SEC Filings

SLRX's Discussions on Twitter

Compare SLRX with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
SLRX Salarius Pharmaceuticals Inc	0.4527	3.70M	4.70M	-4.99M	-5.29M	-6.42
VRTX Vertex Pharmaceuticals Inc	390.30	101.51B	11.39B	3.64B	3.50B	13.99
REGN Regeneron Pharmaceuticals Inc	565.97	59.52B	14.21B	4.46B	3.56B	39.68
ALNY Alnylam Pharmaceuticals Inc	442.73	56.69B	2.46B	-319.09M	-52.09M	-2.47
ARGX Argen X Se Adr	652.43	39.57B	3.06B	1.28B	-614.78M	21.30
ONC Beone Medicines Ltd Adr	309.69	36.56B	3.81B	-644.79M	-669.77M	-6.24

Salarius Pharmaceuticals Inc Stock (SLRX) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-27-20	Initiated	Ladenburg Thalmann	Buy

Salarius Pharmaceuticals Inc Stock (SLRX) Latest News

10:23 AM

Salarius Pharmaceuticals To Implement 1-for-15 Reverse Stock Split - Nasdaq

10:23 AM

08:52 AM

Salarius Pharmaceuticals to implement 1-for-15 reverse stock split By Investing.com - Investing.com Australia

08:52 AM

08:33 AM

Salarius Pharmaceuticals announces 1-for-15 reverse stock split - MarketScreener

08:33 AM

Salarius Pharmaceuticals Announces 1-for-15 Reverse Stock Split - GlobeNewswire

08:33 AM

08:32 AM

Salarius Pharmaceuticals Announces 1-For-15 Reverse Stock Split - TradingView

08:32 AM

08:30 AM

Cancer Drug Developer Salarius Launches Stock Consolidation to Meet Nasdaq Requirements - Stock Titan

08:30 AM

08:03 AM

What MACD and RSI say about Salarius Pharmaceuticals Inc.Rate Cut & Verified Momentum Watchlists - Newser

08:03 AM

07:42 AM

Is a relief rally coming for Salarius Pharmaceuticals Inc. holdersEarnings Recap Summary & AI Driven Stock Movement Reports - Newser

07:42 AM

06:08 AM

What analysts say about Salarius Pharmaceuticals Inc. stock outlookWeekly Trend Report & Safe Entry Point Identification - Newser

06:08 AM

03:48 AM

Salarius Pharmaceuticals Inc. stock prediction for this weekPortfolio Performance Summary & Smart Money Movement Tracker - Newser

03:48 AM

02:11 AM

Advanced analytics toolkit walkthrough for Salarius Pharmaceuticals Inc.Risk Management & Weekly High Conviction Ideas - Newser

02:11 AM

02:09 AM

Technical signs of recovery in Salarius Pharmaceuticals Inc.Weekly Loss Report & Risk Managed Investment Strategies - Newser

02:09 AM

01:57 AM

Using data filters to optimize entry into Salarius Pharmaceuticals Inc.Portfolio Growth Summary & Expert Approved Momentum Ideas - Newser

01:57 AM

Aug 13, 2025

How Salarius Pharmaceuticals Inc. stock performs during market volatility2025 Macro Impact & Free Safe Capital Growth Stock Tips - Newser

Aug 13, 2025

Salarius Pharmaceuticals Q2 2023 Earnings Report | Financial OutlookNews and Statistics - IndexBox

Aug 13, 2025

Will Salarius Pharmaceuticals Inc. see short term momentumWeekly Trade Review & Trade Opportunity Analysis Reports - Newser

Aug 13, 2025

Salarius: Q2 Earnings Snapshot - New Haven Register

Aug 13, 2025

Why Salarius Pharmaceuticals Inc. is moving todayMarket Performance Summary & Proven Capital Preservation Tips - Newser

Aug 13, 2025

What’s next for Salarius Pharmaceuticals Inc. stock priceJuly 2025 Momentum & Weekly Breakout Stock Alerts - Newser

Aug 13, 2025

What’s next for Salarius Pharmaceuticals Inc. stock price [2025 Valuation Update]Stock Portfolio Risk Control - Newser

Aug 13, 2025

Market reaction to Salarius Pharmaceuticals Inc.’s recent news [Forecast Cut]Free Stepwise Trade Signal Implementation - Newser

Aug 13, 2025

Aug 12, 2025

Heatmap analysis for Salarius Pharmaceuticals Inc. and competitorsFree Optimized Watchlist With Daily Adjustments - Newser

Aug 12, 2025

Can Salarius Pharmaceuticals Inc. stock double in the next yearTop ROI Picks for Fast Gains - kangso.co.kr

Aug 12, 2025

Using flow based indicators on Salarius Pharmaceuticals Inc.Free Weekly Stock Opportunity Radar Scanner - Newser

Aug 12, 2025

Aug 11, 2025

How Efficient Is Salarius Pharmaceuticals Inc. at Controlling Operating CostsGrowth Summary Based on Market Positioning - Newser

Aug 11, 2025